Home » Topics » Regulatory » Patents

Patents
RSS

Plasmin/kallikrein inhibitors from Hisamitsu

May 3, 1996

Kureha's new agent for renal disorders

May 3, 1996

Reteplase multiple boluses claimed for thromboembolic conditions

May 3, 1996

Nasal propranolol claimed by RiboGene for angina Rx

May 3, 1996

TEI-9063 structure linked to new patent

May 3, 1996

AHP claims smooth muscle cell proliferation inhibitors for restenosis

May 3, 1996

More research into angiotensin II antagonists at Takeda

May 3, 1996

Takeda discovers new PGDF inhibitors

May 3, 1996

Glaxo Wellcome's newest approach to ARDS

May 3, 1996

RPR describes NMDA/glycine-site antagonists

May 3, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Nov. 11, 2024.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for November 11, 2024.
Sales balloon for GLP-1 drugs from Novo Nordisk, Eli Lilly
BioWorld
Nearly $3.8 billion was earned by Novo Nordisk A/S and Eli Lilly and Co. in the third quarter for their glucagon-like peptide-1 (GLP-1) drugs to treat obesity....
Regulatory actions for Oct. 31, 2024
BioWorld
Regulatory snapshots, including global drug submissions and approvals, clinical trial approvals and other regulatory decisions and designations: Capsida, Electra,...
Australia reimburses Vazkepa a decade after US approval
BioWorld
For the first time, Australians have access to CSL Inc.’s Vazkepa (icosapent ethyl/Vascepa) for managing cardiovascular disease more than a decade after the drug...

BioWorld Premium

Enjoy extended coverage for the most complete market view with BioWorld, BioWorld MedTech, and BioWorld Asia in a single, easy to access subscription.